Advertisement
Screener

Seelos Therapeutics, Inc. Operating Cash Flow

Seelos Therapeutics, Inc. Operating Cash Flow

Seelos Therapeutics, Inc. reported Operating Cash Flow of -$5.61 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-08-14

  • Seelos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$972.00K.
  • Seelos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$4.64M.
  • Seelos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$1.91M.
  • Seelos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$5.75M.
  • Seelos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$23.91M.
  • Seelos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$61.60M.
  • Seelos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$48.99M.
  • Seelos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2016 was -$13.07M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2024-06-30-$972.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$5.61M
10-Q · filed 2024-08-14
-$7.53M
derived: sum of 3 quarters · filed 2024-08-14
-$13.27M
derived: sum of 4 quarters · filed 2024-08-14
2024-03-31-$4.64M
10-Q · filed 2024-05-14
-$6.55M
derived: sum of 2 quarters · filed 2024-05-14
-$12.30M
derived: sum of 3 quarters · filed 2024-05-14
-$18.21M
derived: sum of 4 quarters · filed 2024-08-14
2023-12-31-$1.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
-$7.66M
derived: sum of 2 quarters · filed 2024-03-06
-$13.56M
derived: sum of 3 quarters · filed 2024-08-14
-$23.91M
10-K · filed 2024-03-06
2023-09-30-$5.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$11.65M
derived: sum of 2 quarters · filed 2024-08-14
-$22.00M
10-Q · filed 2023-11-14
-$35.09M
derived: sum of 4 quarters · filed 2024-08-14
2023-06-30-$5.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$16.25M
10-Q · filed 2024-08-14
-$29.34M
derived: sum of 3 quarters · filed 2024-08-14
-$40.42M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$10.35M
10-Q · filed 2024-05-14
-$23.44M
derived: sum of 2 quarters · filed 2024-05-14
-$34.51M
derived: sum of 3 quarters · filed 2024-05-14
-$54.91M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$13.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
-$24.16M
derived: sum of 2 quarters · filed 2024-03-06
-$44.56M
derived: sum of 3 quarters · filed 2024-03-06
-$61.60M
10-K · filed 2024-03-06
2022-09-30-$11.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$31.47M
derived: sum of 2 quarters · filed 2023-11-14
-$48.51M
10-Q · filed 2023-11-14
-$66.85M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$20.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
-$37.44M
10-Q · filed 2023-08-11
-$55.78M
derived: sum of 3 quarters · filed 2023-08-11
-$66.29M
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31-$17.05M
10-Q · filed 2023-05-12
-$35.38M
derived: sum of 2 quarters · filed 2023-05-12
-$45.89M
derived: sum of 3 quarters · filed 2023-05-12
-$54.79M
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31-$18.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10
-$28.85M
derived: sum of 2 quarters · filed 2023-03-10
-$37.74M
derived: sum of 3 quarters · filed 2023-03-10
-$48.99M
10-K · filed 2023-03-10
2021-09-30-$10.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$19.40M
derived: sum of 2 quarters · filed 2022-11-10
-$30.66M
10-Q · filed 2022-11-10
2021-06-30-$8.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
-$20.15M
10-Q · filed 2022-08-05
2021-03-31-$11.25M
10-Q · filed 2022-05-10
2016-12-31-$2.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
-$3.57M
derived: sum of 2 quarters · filed 2017-03-13
-$6.95M
derived: sum of 3 quarters · filed 2017-03-13
-$13.07M
10-K · filed 2017-03-13
2016-09-30-$861.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
-$4.24M
derived: sum of 2 quarters · filed 2016-11-08
-$10.36M
10-Q · filed 2016-11-08
-$11.67M
derived: sum of 4 quarters · filed 2017-03-13
2016-06-30-$3.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$9.50M
10-Q · filed 2016-08-04
-$10.81M
derived: sum of 3 quarters · filed 2017-03-13
-$17.41M
derived: sum of 4 quarters · filed 2017-03-13
2016-03-31-$6.12M
10-Q · filed 2016-05-09
-$7.43M
derived: sum of 2 quarters · filed 2017-03-13
-$14.03M
derived: sum of 3 quarters · filed 2017-03-13
-$22.64M
derived: sum of 4 quarters · filed 2017-03-13
2015-12-31-$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
-$7.90M
derived: sum of 2 quarters · filed 2017-03-13
-$16.52M
derived: sum of 3 quarters · filed 2017-03-13
-$22.64M
10-K · filed 2017-03-13
2015-09-30-$6.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
-$15.21M
derived: sum of 2 quarters · filed 2016-11-08
-$21.33M
10-Q · filed 2016-11-08
2015-06-30-$8.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$14.74M
10-Q · filed 2016-08-04
2015-03-31-$6.13M
10-Q · filed 2016-05-09
2014-03-31-$192.00K
10-Q · filed 2015-05-11
2012-12-31-$672.59K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$3.57M
derived: sum of 2 quarters · filed 2013-03-18
-$7.16M
derived: sum of 3 quarters · filed 2013-03-18
-$12.32M
10-K · filed 2013-03-18
2012-09-30-$2.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
-$6.49M
derived: sum of 2 quarters · filed 2012-11-08
-$11.65M
10-Q · filed 2012-11-08
-$14.07M
derived: sum of 4 quarters · filed 2012-11-08
2012-06-30-$3.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
-$8.75M
10-Q · filed 2012-08-09
-$11.18M
derived: sum of 3 quarters · filed 2012-08-09
-$13.97M
derived: sum of 4 quarters · filed 2012-11-08
2012-03-31-$5.16M
10-Q · filed 2012-05-10
-$7.59M
derived: sum of 2 quarters · filed 2012-05-10
-$10.38M
derived: sum of 3 quarters · filed 2012-11-08
-$12.45M
derived: sum of 4 quarters · filed 2012-11-08
2011-12-31-$2.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-13
-$5.22M
derived: sum of 2 quarters · filed 2012-11-08
-$7.29M
derived: sum of 3 quarters · filed 2012-11-08
-$9.72M
10-K · filed 2012-03-13
2011-09-30-$2.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
-$4.86M
derived: sum of 2 quarters · filed 2012-11-08
-$7.30M
10-Q · filed 2012-11-08
-$9.24M
derived: sum of 4 quarters · filed 2012-11-08
2011-06-30-$2.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-15
-$4.51M
10-Q · filed 2012-08-09
-$6.45M
derived: sum of 3 quarters · filed 2012-05-10
-$8.73M
derived: sum of 4 quarters · filed 2012-05-10
2011-03-31-$2.43M
10-Q · filed 2012-05-10
-$4.37M
derived: sum of 2 quarters · filed 2012-05-10
-$6.66M
derived: sum of 3 quarters · filed 2012-05-10
2010-12-31-$1.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-13
-$4.22M
derived: sum of 2 quarters · filed 2012-03-13
-$6.89M
10-K · filed 2012-03-13
2010-09-30-$2.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$4.95M
10-Q · filed 2011-11-14
2010-06-30-$2.67M
10-Q · filed 2011-08-15
2009-12-31-$3.36M
10-K · filed 2012-03-13